• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的遗传检测实施评估框架的建议

A proposal of a new evaluation framework towards implementation of genetic tests.

机构信息

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United Sates of America.

出版信息

PLoS One. 2019 Aug 5;14(8):e0219755. doi: 10.1371/journal.pone.0219755. eCollection 2019.

DOI:10.1371/journal.pone.0219755
PMID:31381569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6681956/
Abstract

BACKGROUND

The existing frameworks for the evaluation of genetic and genomic applications clearly address the technical and clinical value of a test, but are less concerned with the way genetic services are delivered and organized. We therefore aimed to develop a comprehensive new framework that includes an assessment of service delivery.

METHODS

A new framework was built on the evaluation dimensions identified through a systematic review of the existing frameworks and a Delphi survey of Italian experts in public health genomics.

RESULTS

Our framework has four sections. The first two sections, respectively, guide the evidence collection process for the genetic test (analytic validity; clinical validity; clinical utility; personal utility) and its delivery models (organizational aspects; economic evaluation; ethical, legal and social implications; patient perspective). The third section guides the formulation of the research priorities to be addressed in future research. Finally, the fourth section suggests three criteria to summarize the collected evidence (net benefit, cost-effectiveness, feasibility).

CONCLUSION

We have successfully developed an evaluation framework for the evaluation of genetic tests that includes an assessment of service delivery. It also introduces some neglected evaluation dimensions such as personal utility and patient perspective.

摘要

背景

现有的遗传和基因组应用评估框架明确解决了测试的技术和临床价值问题,但较少关注遗传服务的提供和组织方式。因此,我们旨在开发一个包括服务交付评估的综合新框架。

方法

通过对现有框架进行系统评价和对意大利公共卫生基因组学专家进行德尔菲调查,确定了评估维度,并在此基础上构建了一个新框架。

结果

我们的框架有四个部分。前两个部分分别指导遗传测试的证据收集过程(分析有效性;临床有效性;临床实用性;个人实用性)及其交付模式(组织方面;经济评估;伦理、法律和社会影响;患者视角)。第三部分指导制定未来研究中需要解决的研究重点。最后,第四个部分提出了三个总结所收集证据的标准(净效益、成本效益、可行性)。

结论

我们成功地开发了一个用于评估遗传测试的评估框架,其中包括对服务交付的评估。它还引入了一些被忽视的评估维度,如个人实用性和患者视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b4/6681956/575e2910708c/pone.0219755.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b4/6681956/575e2910708c/pone.0219755.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b4/6681956/575e2910708c/pone.0219755.g001.jpg

相似文献

1
A proposal of a new evaluation framework towards implementation of genetic tests.一种新的遗传检测实施评估框架的建议
PLoS One. 2019 Aug 5;14(8):e0219755. doi: 10.1371/journal.pone.0219755. eCollection 2019.
2
How is genetic testing evaluated? A systematic review of the literature.遗传检测如何评估?文献系统评价。
Eur J Hum Genet. 2018 May;26(5):605-615. doi: 10.1038/s41431-018-0095-5. Epub 2018 Feb 8.
3
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.精准医疗,首次就诊:高度个性化和基于评估的青少年心理健康管理医疗模式。
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383.
4
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
5
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.
6
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.基于互联网的电子学习对临床医生行为和患者结局的有效性:一项系统评价方案。
JBI Database System Rev Implement Rep. 2015 Jan;13(1):52-64. doi: 10.11124/jbisrir-2015-1919.
9
The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.精神分裂症患者在使用抗精神病药物治疗时进行细胞色素 P450 多态性检测的临床效果和成本效益:系统评价和经济评估。
Health Technol Assess. 2010 Jan;14(3):1-157, iii. doi: 10.3310/hta14030.
10
Development and description of GETT: a genetic testing evidence tracking tool.发展和描述 GETT:一个基因检测证据跟踪工具。
Clin Chem Lab Med. 2010 Oct;48(10):1397-407. doi: 10.1515/CCLM.2010.291. Epub 2010 Jul 27.

引用本文的文献

1
Prognosis, treatment decision-making and value: A qualitative exploration of the emerging role of breast cancer prognostic assays.预后、治疗决策与价值:对乳腺癌预后检测新作用的定性探索
PLoS One. 2025 Jul 18;20(7):e0322509. doi: 10.1371/journal.pone.0322509. eCollection 2025.
2
Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: A systematic review of economic evaluations.权衡临床实践中基于多基因风险方法的成本与效益证据:经济评估的系统综述
Am J Hum Genet. 2025 Aug 7;112(8):1735-1753. doi: 10.1016/j.ajhg.2025.05.012. Epub 2025 Jun 12.
3
The current stage of Italy in the implementation of genomics into the National Healthcare System: an application of the B1MG maturity level model.

本文引用的文献

1
How is genetic testing evaluated? A systematic review of the literature.遗传检测如何评估?文献系统评价。
Eur J Hum Genet. 2018 May;26(5):605-615. doi: 10.1038/s41431-018-0095-5. Epub 2018 Feb 8.
2
Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia.患者对遗传信息的体验和利用:一项针对癌症易感性和血栓形成倾向检测患者的横断面研究。
Eur J Hum Genet. 2018 Apr;26(4):518-526. doi: 10.1038/s41431-017-0083-1. Epub 2018 Jan 26.
3
Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.
意大利在将基因组学应用于国家医疗保健系统方面的当前阶段:B1MG成熟度水平模型的应用
Front Public Health. 2025 Apr 16;13:1425990. doi: 10.3389/fpubh.2025.1425990. eCollection 2025.
4
Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditions.在生殖遗传携带者筛查项目设计中考虑疾病严重程度:严重疾病筛查
Eur J Hum Genet. 2025 Mar;33(2):194-198. doi: 10.1038/s41431-024-01738-0. Epub 2024 Nov 25.
5
Advancing hospital-based health technology assessment: evaluating genomic panel contracting strategies for blood tumors through a multimethodology.推进基于医院的卫生技术评估:通过多方法学评估血液肿瘤基因检测面板合同策略。
Int J Technol Assess Health Care. 2023 Dec 22;39(1):e76. doi: 10.1017/S0266462323002751.
6
[Genomics in Public Health Scientific evidence and prospects for integration in the prevention practice].[公共卫生中的基因组学:科学证据及整合至预防实践的前景]
J Prev Med Hyg. 2023 Jan 13;63(3 Suppl 2):E1-E29. doi: 10.15167/2421-4248/jpmh2022.63.3s2. eCollection 2023 Mar.
7
An innovative framework to determine the implementation level of personalized medicine: A systematic review.创新框架确定个体化医学实施水平:系统评价。
Front Public Health. 2023 Feb 3;11:1039688. doi: 10.3389/fpubh.2023.1039688. eCollection 2023.
8
Disclosure of Genetic Risk Factors for Alzheimer's Disease to Cognitively Healthy Individuals-From Current Practice towards a Personalised Medicine Scenario.向认知健康个体披露阿尔茨海默病的遗传风险因素——从当前实践到个性化医疗场景
Biomedicines. 2022 Dec 8;10(12):3177. doi: 10.3390/biomedicines10123177.
9
From the patient to the population: Use of genomics for population screening.从患者到人群:基因组学在人群筛查中的应用。
Front Genet. 2022 Oct 24;13:893832. doi: 10.3389/fgene.2022.893832. eCollection 2022.
10
Managing the introduction of genomic applications into the National Health Service: A special challenge for health technology assessment in Italy.将基因组应用引入国民保健服务体系的管理:意大利卫生技术评估面临的特殊挑战。
Front Public Health. 2022 Aug 10;10:932093. doi: 10.3389/fpubh.2022.932093. eCollection 2022.
哪些林奇综合征筛查方案可以在“现实世界”中实施?一项经济评估的系统综述。
Genet Med. 2018 Oct;20(10):1131-1144. doi: 10.1038/gim.2017.244. Epub 2018 Jan 4.
4
Identification of Delivery Models for the Provision of Predictive Genetic Testing in Europe: Protocol for a Multicentre Qualitative Study and a Systematic Review of the Literature.欧洲提供预测性基因检测的交付模式识别:多中心定性研究方案及文献系统综述
Front Public Health. 2017 Aug 22;5:223. doi: 10.3389/fpubh.2017.00223. eCollection 2017.
5
No Shortcuts on the Long Road to Evidence-Based Genomic Medicine.循证基因组医学漫漫长路无捷径。
JAMA. 2017 Jul 4;318(1):27-28. doi: 10.1001/jama.2017.6315.
6
Personal utility in genomic testing: a systematic literature review.基因检测中的个人效用:一项系统的文献综述
Eur J Hum Genet. 2017 Jun;25(6):662-668. doi: 10.1038/ejhg.2017.10. Epub 2017 Mar 15.
7
Defining personal utility in genomics: A Delphi study.界定基因组学中的个人效用:一项德尔菲研究。
Clin Genet. 2017 Sep;92(3):290-297. doi: 10.1111/cge.12998. Epub 2017 Apr 19.
8
Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.哪些BRCA基因检测项目已准备好在医疗保健中实施?一项经济评估的系统综述。
Genet Med. 2016 Dec;18(12):1171-1180. doi: 10.1038/gim.2016.29. Epub 2016 Apr 14.
9
Current state of genomic policies in healthcare among EU member states: results of a survey of chief medical officers.欧盟成员国医疗保健中基因组政策的现状:首席医疗官调查结果。
Eur J Public Health. 2017 Oct 1;27(5):931-937. doi: 10.1093/eurpub/ckw155.
10
Clinical utility of genetic and genomic services: context matters.遗传和基因组服务的临床效用:背景很重要。
Genet Med. 2016 Jul;18(7):672-4. doi: 10.1038/gim.2015.153. Epub 2015 Dec 10.